Oricula Therapeutics
0 followers
‌
Oricula Therapeutics is working to develop the first medication to be approved to prevent drug-induced hearing loss.
Industries
Headquarters
Employees
Links
Org chart
Vince Groppi
Chief Executive Officer
Vince Groppi
Collapse
Graham Johnson
NuPharmAdvise, President
Marc Bailie
Chief Development Officer, INDS
David W. Raible
University of Washington, Professor
Henry Ou
University of Washington, Assoc Professor
Edwin W. Rubel
University of Washington, Chaired Professor
